D
Olema Pharmaceuticals, Inc. OLMA
$5.10 $0.2054.19% NASDAQ
Recommendation
Prev Close
$4.89
Volume
396,273
Avg Vol (90D)
1,072,752
Market Cap
$334.15M
Dividend & Yield
--
52-Week Range
$2.86 - $16.62
P/E (TTM)
--
EPS (TTM)
-$2.21
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Olema Pharmaceuticals (OLMA, $4.89) RSI Indicator left the overbought zone on April 28, 2025
4/29/2025 - Tickeron - Stocks
Olema Oncology Announces New Preclinical Data for OP-3136 Demonstrating Anti-Tumor Activity in Multiple Solid Tumor Models at AACR 2025
4/25/2025 - Globe Newswire
Wall Street Analysts Think Olema Pharmaceuticals (OLMA) Could Surge 433.13%: Read This Before Placing a Bet
4/24/2025 - Zacks Investment Research
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Shares Sold by Silverarc Capital Management LLC
4/24/2025 - MarketBeat
1,651,982 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Purchased by Avoro Capital Advisors LLC
4/23/2025 - MarketBeat
Bain Capital Life Sciences Investors LLC Invests $43.55 Million in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
4/23/2025 - MarketBeat
Olema Pharmaceuticals (OLMA, $4.75) RSI Indicator left the overbought zone on April 21, 2025
4/22/2025 - Tickeron - Stocks
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Short Interest Update
4/21/2025 - MarketBeat
Vanguard Group Inc. Grows Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
4/20/2025 - MarketBeat
Olema Pharmaceuticals (OLMA, $4.26) Aroon Indicator entered a Downtrend on April 16, 2025.
4/17/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $4.06) entered Uptrend as Momentum indicator ascends above 0 level on Apr 14, 2025
4/15/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $3.77) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 11, 2025
4/12/2025 - Tickeron - Technical Analysis
Wellington Management Group LLP Has $8.84 Million Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
4/12/2025 - MarketBeat
Olema Pharmaceuticals (OLMA, $3.41) RSI Indicator left the oversold zone on April 10, 2025
4/11/2025 - Tickeron - Stocks
After Plunging -30.16% in 4 Weeks, Here's Why the Trend Might Reverse for Olema Pharmaceuticals (OLMA)
4/10/2025 - Zacks Investment Research
Olema Pharmaceuticals: Maybe Not Differentiated, But Could Find A Niche In A Valuable Market
4/8/2025 - SeekingAlpha
Olema Pharmaceuticals: Maybe Not Differentiated, But Could Find A Niche In A Valuable Market
4/8/2025 - Seeking Alpha - Long Ideas
Pictet Asset Management Holding SA Boosts Stock Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA)
4/4/2025 - MarketBeat
Olema Pharmaceuticals (OLMA, $3.33) Aroon Indicator entered a Downtrend on April 02, 2025.
4/3/2025 - Tickeron - Stocks
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4/2/2025 - Globe Newswire
Olema Pharmaceuticals (OLMA, $3.34) Aroon Indicator entered a Downtrend on April 01, 2025.
4/2/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $3.34) Moving Average Convergence Divergence (MACD) Histogram turned negative on April 1, 2025
4/2/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $3.76) Aroon Indicator entered a Downtrend on March 31, 2025.
4/1/2025 - Tickeron - Stocks
Olema Pharmaceuticals (OLMA, $3.76) RSI Indicator left the oversold zone on March 31, 2025
4/1/2025 - Tickeron - Stocks
Insiders Could Have Profited By Holding onto Olema Pharmaceuticals Shares Despite 13% Drop
4/1/2025 - Simply Wall St
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$141.87M
EBIT (TTM)
-$142.26M
Net Income (TTM)
-$129.47M
Balance Sheet
Total Assets (Q)
$450.98M
Total Debt (Q)
$1.43M
Total Liabilities (Q)
$42.02M
Book Value Per Share (Q)
$5.50
Cash Flow
Cash from Operations (TTM)
-$104.35M
Cash from Investing (TTM)
-$93.53M
Cash from Financing (TTM)
$268.82M
Net Change in Cash (TTM)
$70.94M
Filings
Filing Date
Tuesday, March 18, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.27
7-Day Total Return
15.27%
30-Day Total Return
14.49%
60-Day Total Return
-16.61%
90-Day Total Return
-20.89%
Year to Date Total Return
-8.53%
1-Year Total Return
-49.85%
2-Year Total Return
-6.17%
3-Year Total Return
99.80%
5-Year Total Return
--
52-week Low
Apr 07, 2025 - $2.86
52-week High
Aug 01, 2024 - $16.62
Valuation
Market Cap
$334.15M - Small Cap
Enterprise Value
-$98.51M
Price/Sales (TTM)
--
Price/Book (Q)
0.89
Dividends and Shares
Shares Outstanding
65.79M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
olema.com
Phone Number
415 651 3316
Address
780 Brannan Street
San Francisco, CA 94103
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women’s cancers. The company’s lead product... more
NASDAQ 04/29/2025 3:45PM Eastern Quotes delayed